|
|
Volumn 17, Issue 6, 2000, Pages 1231-1235
|
|
p21WAF1/CIP1 protein expression in primary ovarian cancer.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CDKN1A PROTEIN, HUMAN;
CISPLATIN;
CYCLIN DEPENDENT KINASE INHIBITOR 1A;
CYCLINE;
TUMOR PROTEIN;
ADULT;
AGED;
ARTICLE;
BIOSYNTHESIS;
CANCER STAGING;
CELL CYCLE;
COMPARATIVE STUDY;
CYSTADENOCARCINOMA;
DISEASE COURSE;
ENDOMETRIOID CARCINOMA;
FEMALE;
GENE EXPRESSION REGULATION;
GENETICS;
HUMAN;
LIFE TABLE;
METABOLISM;
METASTASIS;
MIDDLE AGED;
MINIMAL RESIDUAL DISEASE;
OMENTUM;
OVARY;
OVARY TUMOR;
PATHOLOGY;
PERITONEUM TUMOR;
SURVIVAL;
TREATMENT OUTCOME;
TUMOR RECURRENCE;
TUMOR SUPPRESSOR GENE;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, ENDOMETRIOID;
CELL CYCLE;
CISPLATIN;
CYCLIN-DEPENDENT KINASE INHIBITOR P21;
CYCLINS;
CYSTADENOCARCINOMA, MUCINOUS;
CYSTADENOCARCINOMA, SEROUS;
DISEASE PROGRESSION;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GENES, P53;
HUMANS;
LIFE TABLES;
MIDDLE AGED;
NEOPLASM PROTEINS;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
NEOPLASM, RESIDUAL;
OMENTUM;
OVARIAN NEOPLASMS;
OVARY;
PERITONEAL NEOPLASMS;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
|
EID: 0034543071
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.17.6.1231 Document Type: Article |
|
Times cited : (55)
|
|
References (0)
|
